132 related articles for article (PubMed ID: 33016327)
1. POM121 is a novel marker for predicting the prognosis of laryngeal cancer.
Zhao R; Tang G; Wang T; Zhang L; Wang W; Zhao Q; Zhao K
Histol Histopathol; 2020 Nov; 35(11):1285-1293. PubMed ID: 33016327
[TBL] [Abstract][Full Text] [Related]
2. POM121 overexpression is related to a poor prognosis in colorectal cancer.
Wang T; Sun H; Bao Y; En R; Tian Y; Zhao W; Jia L
Expert Rev Mol Diagn; 2020 Mar; 20(3):345-353. PubMed ID: 31858845
[No Abstract] [Full Text] [Related]
3. POM121 is identified as a novel prognostic marker of oral squamous cell carcinoma.
Ma H; Li L; Jia L; Gong A; Wang A; Zhang L; Gu M; Tang G
J Cancer; 2019; 10(19):4473-4480. PubMed ID: 31528211
[No Abstract] [Full Text] [Related]
4. Prostate tumor overexpressed-1, in conjunction with human papillomavirus status, predicts outcome in early-stage human laryngeal squamous cell carcinoma.
Yang L; Wang H; Wang Y; He Z; Chen H; Liang S; He S; Wu S; Song L; Chen Y
Oncotarget; 2016 May; 7(22):31878-91. PubMed ID: 26992242
[TBL] [Abstract][Full Text] [Related]
5. POM121 promotes the proliferation and metastasis of gastric cancer via PI3K/AKT/MYC pathway.
Kang C; Jia L; Hao L; Zhang N; Liu Y; Zhang L
Am J Cancer Res; 2023; 13(2):485-497. PubMed ID: 36895982
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of
Zhang S; Zheng C; Li D; Bei C; Zhang H; Tian R; Song X; Zhu X; Tan S
Genet Test Mol Biomarkers; 2020 Dec; 24(12):819-824. PubMed ID: 33296260
[No Abstract] [Full Text] [Related]
7. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
Zhang XW; Liu N; Chen S; Wang Y; Zhang ZX; Sun YY; Qiu GB; Fu WN
Diagn Pathol; 2015 Apr; 10():22. PubMed ID: 25879432
[TBL] [Abstract][Full Text] [Related]
8. Achaete-scute complex homologue-1 promotes development of laryngocarcinoma via facilitating the epithelial-mesenchymal transformation.
Ma H; Du X; Zhang S; Wang Q; Yin Y; Qiu X; Da P; Yue H; Wu H; Xu F
Tumour Biol; 2017 Jun; 39(6):1010428317705752. PubMed ID: 28618959
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of POM121 is linked to prostate cancer aggressiveness and serves as a prognostic biomarker.
Becker F; Offermann A; Roesch MC; Joerg V; Roth D; Lubczyk V; Kuefer R; Sailer V; Kirfel J; Merseburger AS; Perner S
Urol Oncol; 2022 Aug; 40(8):380.e11-380.e18. PubMed ID: 35725938
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of mitogen-activated protein kinase kinase 4 and nuclear factor-kappaB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.
Huang C; Huang K; Wang C; Jiang ZD; Li XX; Wang HP; Chen HY
Oncol Rep; 2009 Jul; 22(1):89-95. PubMed ID: 19513509
[TBL] [Abstract][Full Text] [Related]
11. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
[TBL] [Abstract][Full Text] [Related]
12. Correlation of ECM1 expression level with the pathogenesis and metastasis of laryngeal carcinoma.
Gu M; Guan J; Zhao L; Ni K; Li X; Han Z
Int J Clin Exp Pathol; 2013; 6(6):1132-7. PubMed ID: 23696932
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of yes‑associated protein is associated with the malignant status and prognosis of laryngeal squamous cell carcinoma.
Pan C; Du Z; Cai Z; Liu Y; Sun Y; Chen J; Tong T; Chen Q; Zhou L; Bing D; Tao Y; Chu H
Mol Med Rep; 2017 Oct; 16(4):4934-4940. PubMed ID: 28791393
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of microRNA expression profiling in highly metastatic laryngocarcinoma cells.
Chen L; Liu S; Li K; Qi J; Liu C; Zong L; Zhang Y; Zhao J; Zhai X; Li J; Kong X; Yang S; Liu M
Acta Otolaryngol; 2018 Dec; 138(12):1105-1111. PubMed ID: 30702035
[TBL] [Abstract][Full Text] [Related]
15. Nuclear pore protein POM121 regulates subcellular localization and transcriptional activity of PPARγ.
Yu Y; Farooq MS; Eberhart Meessen S; Jiang Y; Kato D; Zhan T; Weiss C; Seger R; Kang W; Zhang X; Yu J; Ebert MPA; Burgermeister E
Cell Death Dis; 2024 Jan; 15(1):7. PubMed ID: 38177114
[TBL] [Abstract][Full Text] [Related]
16. The expression and function of epithelial membrane protein 1 in laryngeal carcinoma.
Li H; Zhang X; Jiang X; Ji X
Int J Oncol; 2017 Jan; 50(1):141-148. PubMed ID: 27909719
[TBL] [Abstract][Full Text] [Related]
17. LAMP1 expression is associated with malignant behaviours and predicts unfavourable prognosis in laryngeal squamous cell carcinoma.
Lu M; Zhu H; Wang X; Zhang D; Xiong L; Zhu J; Mao Y; Qiang J
Pathology; 2016 Dec; 48(7):684-690. PubMed ID: 27788920
[TBL] [Abstract][Full Text] [Related]
18. FFAR4 promotes cell proliferation and migration and servers as a potential biomarker for clinicopathological characteristics and prognosis in laryngocarcinoma.
Zhou LZ; Cui YX; Wang WZ; Wu J; Sun Z; Ma SY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7438-7444. PubMed ID: 31539131
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of HAX-1 expression in laryngeal carcinoma.
You Y; Yao H; You B; Li X; Ni H; Shi S; Shan Y; Cao X
Auris Nasus Larynx; 2015 Aug; 42(4):299-304. PubMed ID: 25554539
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-21 in laryngeal squamous cell carcinoma: Diagnostic and prognostic features.
Erkul E; Yilmaz I; Gungor A; Kurt O; Babayigit MA
Laryngoscope; 2017 Feb; 127(2):E62-E66. PubMed ID: 27545281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
